Immuneering CorporationIMRXNASDAQ
Loading
Year-over-year operating income growth rate
| Period | Value |
|---|---|
| Q4 2025 | 10.58% |
| Q3 2025 | -4.22% |
| Q2 2025 | 4.69% |
| Q1 2025 | 16.56% |
| Q4 2024 | -21.50% |
| Q3 2024 | -2.41% |
| Q2 2024 | 2.69% |
| Q1 2024 | 5.99% |
| Q4 2023 | -17.06% |
| Q3 2023 | -3.12% |
| Q2 2023 | 8.00% |
| Q1 2023 | -4.97% |
| Q4 2022 | -6.04% |
| Q3 2022 | -13.24% |
| Q2 2022 | 9.90% |
| Q1 2022 | -16.28% |
| Q4 2021 | -30.11% |
| Q3 2021 | -6.91% |
| Q2 2021 | -28.14% |
| Q1 2021 | -6.85% |
| Q4 2020 | -32.64% |
| Q3 2020 | -22.00% |
| Q2 2020 | -11.34% |
| Q1 2020 | 0.00% |